Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.Clin Vaccine Immunol. 2007 Jul; 14(7):926-8.CV
Abstract
In the event of another influenza virus pandemic, strategies for effective mass vaccination will urgently be needed. We used a novel transdermal patch delivery technology, known as the PassPort system, to vaccinate mice with recombinant H5 hemagglutinin with or without immunomodulators. This needle-free form of vaccine delivery induced robust serum antibody responses that were augmented by different immunomodulators that stimulated the innate immune system and protected mice against lethal challenge with a highly pathogenic avian H5N1 influenza virus.
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
17494637
Citation
Garg, Sanjay, et al. "Needle-free Skin Patch Delivery of a Vaccine for a Potentially Pandemic Influenza Virus Provides Protection Against Lethal Challenge in Mice." Clinical and Vaccine Immunology : CVI, vol. 14, no. 7, 2007, pp. 926-8.
Garg S, Hoelscher M, Belser JA, et al. Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. Clin Vaccine Immunol. 2007;14(7):926-8.
Garg, S., Hoelscher, M., Belser, J. A., Wang, C., Jayashankar, L., Guo, Z., Durland, R. H., Katz, J. M., & Sambhara, S. (2007). Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. Clinical and Vaccine Immunology : CVI, 14(7), 926-8.
Garg S, et al. Needle-free Skin Patch Delivery of a Vaccine for a Potentially Pandemic Influenza Virus Provides Protection Against Lethal Challenge in Mice. Clin Vaccine Immunol. 2007;14(7):926-8. PubMed PMID: 17494637.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.
AU - Garg,Sanjay,
AU - Hoelscher,Mary,
AU - Belser,Jessica A,
AU - Wang,Chong,
AU - Jayashankar,Lakshmi,
AU - Guo,Zhu,
AU - Durland,Ross H,
AU - Katz,Jacqueline M,
AU - Sambhara,Suryaprakash,
Y1 - 2007/05/09/
PY - 2007/5/15/pubmed
PY - 2007/11/6/medline
PY - 2007/5/15/entrez
SP - 926
EP - 8
JF - Clinical and vaccine immunology : CVI
JO - Clin Vaccine Immunol
VL - 14
IS - 7
N2 - In the event of another influenza virus pandemic, strategies for effective mass vaccination will urgently be needed. We used a novel transdermal patch delivery technology, known as the PassPort system, to vaccinate mice with recombinant H5 hemagglutinin with or without immunomodulators. This needle-free form of vaccine delivery induced robust serum antibody responses that were augmented by different immunomodulators that stimulated the innate immune system and protected mice against lethal challenge with a highly pathogenic avian H5N1 influenza virus.
SN - 1556-6811
UR - https://www.unboundmedicine.com/medline/citation/17494637/Needle_free_skin_patch_delivery_of_a_vaccine_for_a_potentially_pandemic_influenza_virus_provides_protection_against_lethal_challenge_in_mice_
L2 - http://cvi.asm.org/cgi/pmidlookup?view=long&pmid=17494637
DB - PRIME
DP - Unbound Medicine
ER -